Androgens, health and sexuality in women and men

References

• Agarwal, P.K., & Oefelein, M.G. (2005). Testosterone replacement therapy after primary treatment for prostate cancer. Journal of Urology, 173, 533–536.
   PubMed Web of Science ®Google Scholar
• Allan, C.A., Strauss, B.J., Burger, H.G., Forbes, E.A., & McLachlan, R.I. (2008). Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non obese aging men. Journal of Clinical Endocrinology and Metabolism, 93, 139–146.
   PubMed Web of Science ®Google Scholar
• Allan, C.A., Strauss, B.J., & McLachlan, R.I. (2007). Body composition, metabolic syndrome and testosterone in ageing men. International Journal of Impotence Research, 19, 448–457.
   PubMed Web of Science ®Google Scholar
• Araujo, A.B., Esche, G.R., Kupelian, V., O'Donnell, A.B., Travison, T.G., Williams, R.E., et al. (2007). Prevalence of symptomatic androgen deficiency in men. Journal of Clinical Endocrinology and Metabolism, 92, 4241–4247.
   PubMed Web of Science ®Google Scholar
• Araujo, A.B., O'Donnell, A., Brambilla, D.J., Simpson, W.B., Longcope, C., Matsumoto, A.M., et al. (2004). Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism, 89, 5920–5926.
   PubMed Web of Science ®Google Scholar
• Aziz, A., Brannstrom, M., Bergquist, C., & Silfverstolpe, G. (2005). Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertility and Sterility, 83, 1021–1028.
   PubMed Web of Science ®Google Scholar
• Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., et al. (2002). Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertility and Sterility, 77, 660–665.
   PubMed Web of Science ®Google Scholar
• Barad, D., Brill, H., & Gleicher, N. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Journal of Assisted Reproduction and Genetics, 24, 629–634.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor, E., Young, R., Notelovitz, M., Sullivan, J., Wiita, B., Yang, H.M., et al. (1999). A two year double blind comparison of oestrogen–androgen and conjugated oestrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. Journal of Reproductive Medicine, 44, 1012–1020.
   PubMed Web of Science ®Google Scholar
• Basson, R. (2001). Female sexual response: the role of drugs in the management of sexual dysfunction. Obstetrics and Gynecology, 98, 350–353.
   PubMed Web of Science ®Google Scholar
• Basson, R. (2008). Women's sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 20, 466–478.
   PubMed Web of Science ®Google Scholar
• Basson, R., Berman, J., Burnett, A., Derogatis, L., Ferguson, D., Fourcroy, J., et al. (2000). Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. Journal of Urology, 163, 888–893.
   PubMed Web of Science ®Google Scholar
• Basson, R., Brotto, L.A., Laan, E., Redmond, G., & Utian, W.H. (2005). Assessment and management of women's sexual dysfunctions: problematic desire and arousal. Journal of Sexual Medicine, 2, 291–300.
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., et al. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995–2010.
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 2536–2559.
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007). Sexual dysfunction in men and women with endocrine disorders. Lancet, 369(9561), 597–611.
   PubMed Web of Science ®Google Scholar
• Black, A.M., Day, A.G., & Morales, A. (2004). The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU International, 94, 1066–1070.
   PubMed Web of Science ®Google Scholar
• Brand, J.S., & Van Der Schouw, Y.T. (2010). Testosterone, SHBG and cardiovascular health in post-menopausal women. International Journal of Impotence Research, 22, 91–104.
   PubMed Web of Science ®Google Scholar
• Braunstein, G.D. (2007). Safety of testosterone treatment in postmenopausal women. Fertility and Sterility, 88, 1–17.
   PubMed Web of Science ®Google Scholar
• Braunstein, G.D., Sundwall, D.A., Katz, M., Shifren, J.L., Buster, J.E., Simon, J.A., et al. (2005). Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Archives of Internal Medicine, 165, 1582–1589.
   PubMed Web of Science ®Google Scholar
• Brock, G., Nicolosi, A., Glasser, D.B., Gingell, C., & Buvat, J. (2002). Sexual problems reported by men and women in 28 countries: results of the global study of sexual attitudes and behaviours. International Journal of Impotence Research, 14, S57–S58.
   Google Scholar
• Büchter, D., Behre, H.M., Kliesch, S., & Nieschlag, E. (1998). Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology, 139, 298–303.
   PubMed Web of Science ®Google Scholar
• Bunch, T.J., Abraham, D., Wang, S., & Meikle, A.W. (2002). Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. The Aging Male, 5, 38–46.
   PubMedGoogle Scholar
• Burger, G.H., Hailes, J., Menelaus, M., Nelson, J., Hudson, B., & Balazs, N. (1984). The management of persistent menopausal symptoms with oestradiol–testosterone implants: clinical lipid and hormonal results. Maturitas, 6, 351–358.
   PubMed Web of Science ®Google Scholar
• Burger, H., Hailes, J., Nelson, J., & Menelaus, M. (1987). Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. BMJ, 294, 936–937.
   PubMed Web of Science ®Google Scholar
• Burris, A.S., Clark, R.V., Vantman, D.J., & Sherins, R.J. (1988). A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertility and Sterility, 50, 343–347.
   PubMed Web of Science ®Google Scholar
• Buster, J.E., Kingsberg, S.A., Aguirre, O., Brown, C., Breaux, J.G., Buch, A., et al. (2005). Testosterone patch for low sexual desire in surgically menopausal women: a randomised trial. Obstetrics and Gynecology, 105, 944–952.
   PubMed Web of Science ®Google Scholar
• Buvat, J., & Bou Jaoudé, G. (2006). Significance of hypogonadism in erectile dysfunction. World Journal of Urology, 24, 657–667.
   PubMed Web of Science ®Google Scholar
• Buvat, J., & Lemaire, A. (1997). Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. Journal of Urology, 158, 1764–1767.
   PubMed Web of Science ®Google Scholar
• Buvat, J., Maggi, M., Gooren, L., Guay, A.T., Kaufman, J., Morgentaler, A., et al. (2010). Endocrine aspects of male sexual dysfunctions. Journal of Sexual Medicine, 7, 1627–1656.
   PubMed Web of Science ®Google Scholar
• Calof, O.M., Singh, A.B., Lee, M.L., Kenny, A.M., Urban, R.J., Tenover, J.L., et al. (2005). Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 60, 1451–1457.
   PubMed Web of Science ®Google Scholar
• Carpenter, W.R., Robinson, W.R., & Godley, P.A. (2008). Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. Journal of the National Cancer Institute, 100, 158–159.
   PubMed Web of Science ®Google Scholar
• Chudakov, B., Ben Zion, I.Z., & Belmaker, R.H. (2007). Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the Arizona Sexual Experiences Scale for Females and Sexual Function Questionnaire. Journal of Sexual Medicine, 4, 204–208.
   PubMed Web of Science ®Google Scholar
• Citron, J.T., Ettinger, B., Rubinoff, H., Ettinger, V.M., Minkoff, J., Hom, F., et al. (1996). Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism. Journal of Urology, 155, 529–533.
   PubMed Web of Science ®Google Scholar
• Clayton, A.H. (2003). Sexual function and dysfunction in women. The Psychiatric Clinics of North America, 26, 673–678.
   PubMed Web of Science ®Google Scholar
• Clayton, A.H., Goldfischer, E.R., Goldstein, I., DeRogatis, L., Lewis-D'Agostino, D., & Pyke, R. (2009). Validation of the Decreased Sexual Desire Screener© (DSDS©): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). Journal of Sexual Medicine, 6, 730–738.
   PubMed Web of Science ®Google Scholar
• Dabbs, M., & Dabbs, J.M. (2000). Heroes, rogues, and lovers: testosterone and behavior. New York: McGraw-Hill.
   Google Scholar
• Davis, S.R. (2002). The effects of tibolone on mood and libido. Menopause, 9, 162–170.
   PubMed Web of Science ®Google Scholar
• Davis, S.R., Davison, S.L., Donath, S., & Bell, R.J. (2005). Circulating androgen levels and self-reported sexual function in women. JAMA, 294, 91–96.
   PubMed Web of Science ®Google Scholar
• Davis, S.R., McCloud, P., Strauss, B.J., & Burger, H. (1995). Testosterone enhances oestradiol's effects on postmenopausal bone density and sexuality. Maturitas, 21, 227–236.
   PubMed Web of Science ®Google Scholar
• Davis, S.R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., et al. (2008). Testosterone for low libido in post menopausal women not taking estrogen. New England Journal of Medicine, 359, 2005–2017.
   PubMed Web of Science ®Google Scholar
• Davison, S., Bell, R., Donath, S., Montalto, J.G., & Davis, S.R. (2005). Androgen levels in adult females: changes with age, menopause and oophorectomy. Journal of Clinical Endocrinology and Metabolism, 90, 3847–3853.
   PubMed Web of Science ®Google Scholar
• Dennerstein, L., Hayes, R., Sand, M., & Lehert, P. (2009). Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire. Journal of Sexual Medicine, 6, 1668–1673.
   PubMed Web of Science ®Google Scholar
• Dennerstein, L., Randolph, J., Taffe, J., Dudley, E., & Burger, H. (2002). Hormones, mood, sexuality and the menopause transition. Fertility & Sterility, 77(Suppl. 4), S42–S48.
   Web of Science ®Google Scholar
• Derby, C.A., Zilber, S., Brambilla, D., Morales, K.H., & McKinlay, J.B. (2006). Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts male ageing study. Clinical Endocrinology (Oxford), 65, 125–131.
   PubMed Web of Science ®Google Scholar
• Derogatis, L., Rust, J., Golombok, S., Bouchard, C., Nachtigall, L., Rodenberg, C., et al. (2004). Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. Journal of Sex & Marital Therapy, 30, 25–36.
   PubMed Web of Science ®Google Scholar
• Dobs, A.S., Nguyen, T., Pace, C., & Roberts, C.P. (2002). Differential effects of oral estrogen versus oral estrogen–androgen replacement therapy on body composition in post menopausal women. Journal of Clinical Endocrinology and Metabolism, 87, 1509–1516.
   PubMed Web of Science ®Google Scholar
• Dow, M.G., Hart, D.M., & Forrest, C.A. (1983). Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. British Journal of Obstetrics and Gynaecology, 90, 361–366.
   PubMedGoogle Scholar
• Drinka, P.J., Jochen, A.L., Cuisinier, M., Bloom, R., Rudman, I., & Rudman, D. (1995). Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. Journal of the American Geriatrics Society, 43, 899–901.
   PubMed Web of Science ®Google Scholar
• Farquhar, C.M., Harvey, S.A., Yu, Y., Sadler, L., & Stewart, E.W. (2006). A prospective study of three years of outcomes after hysterectomy with and without oophorectomy. American Journal of Obstetrics and Gynecology, 194, 714–717.
   Web of Science ®Google Scholar
• Floter, A., Nathorst-Boos, J., Carlstrom, K., & von Schoultz, B. (2002). Addition of testosterone to estrogen replacement therapy in oophorectomised women: effects on sexuality and wellbeing. Climacteric, 5, 357–365.
   PubMed Web of Science ®Google Scholar
• Freitas, S.S., Barrett-Connor, E., Ensrud, K.E, Fink, H.A., Bauer, D.C., Cawthon, P.M., et al. (2007). Rate and circumstances of clinical vertebral fractures in older men. Osteoporosis International, 19, 615–623.
   PubMed Web of Science ®Google Scholar
• Gelfand, M.M., & Witta, B. (1997). Androgen and estrogen–androgen hormone replacement therapy: a review of the safety literature, 1941–1996. Clinical Therapeutics, 19, 383–404.
   PubMed Web of Science ®Google Scholar
• Goldfischer, E.R., Clayton, A.H., Goldstein, I., Lewis-D'Agostino, D., & Pyke, R. (2008). Decreased Sexual Desire Screener© (DSDS©) for diagnosis of Hypoactive Sexual Desire Disorder in women. Obstetrics and Gynecology, 111, 109S.
   Web of Science ®Google Scholar
• Gooren, L.J. (2010). Androgens and male aging: current evidence of safety and efficacy. Asian Journal of Andrology, 12, 136–151.
   PubMed Web of Science ®Google Scholar
• Goto, M., Piper Hanley, K., Marcos, J., Wood, P.J., Wright, S., Postle, A.D., et al. (2006). In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. Journal of Clinical Investigation, 116, 953–960.
   PubMed Web of Science ®Google Scholar
• Graziottin, A. (2007). Prevalence and evaluation of sexual health problems – HSDD in Europe. Journal of Sexual Medicine, 4(Suppl. 3), 211–219.
   PubMedGoogle Scholar
• Graziottin, A., Koochaki, P.E., Rodenberg, C., & Dennerstein, L. (2009). The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. Journal of Sexual Medicine, 6, 2143–2153.
   PubMed Web of Science ®Google Scholar
• Greco, E.A., Spera, G., & Aversa, A. (2006). Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. European Urology, 50, 940–947.
   PubMed Web of Science ®Google Scholar
• Guay, A., Jacobson, J., Munarriz, R., Traish, A., Talakoub, L., Quirk, F., et al. (2004). Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. International Journal of Impotence Research, 16, 121–129.
   PubMed Web of Science ®Google Scholar
• Gurnell, E.M., Hunt, P.J., Curran, S.E., Conway, C.L., Pullenayegum, E.M., Huppert, F.A., et al. (2008). Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism, 93, 400–409.
   PubMed Web of Science ®Google Scholar
• Hackett, G., Kell, P., Ralph, D., Dean, J., Price, D., Speakman, M., et al. (2008). British Society for Sexual Medicine guidelines on the management of erectile dysfunction. Journal of Sexual Medicine, 5, 1841–1865.
   PubMed Web of Science ®Google Scholar
• Harsh, V., McGarvey, E.L., & Clayton, A.H. (2008). Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study. Journal of Sexual Medicine, 5, 640–645.
   PubMed Web of Science ®Google Scholar
• Hayes, R.D., Dennerstein, L., Bennett, C.M., Koochaki, P.E., Leiblum, S.R., & Graziottin, A. (2007). Relationship between hypoactive sexual desire disorder and aging. Fertility and Sterility, 87, 107–112.
   PubMed Web of Science ®Google Scholar
• Kalyani, R.R., & Dobs, A.S. (2007). Androgen deficiency, diabetes, and the metabolic syndrome in men. Current Opinion in Endocrinology, Diabetes, and Obesity, 14, 226–234.
   PubMedGoogle Scholar
• Kapoor, D., Aldred, H., Clark, S., Channer, K.S., & Jones, T.H. (2007a). Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care, 30, 911–917.
   PubMed Web of Science ®Google Scholar
• Kapoor, D., Channer, K., Aldred, H., Hugh Jones, T., & Clark, S. (2007b). Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes Care, 30, 911–917.
   PubMed Web of Science ®Google Scholar
• Kenny, A.M., Prestwood, K.M., & Raisz, L.G. (2000). Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels. Endocrine Research, 26, 153–168.
   PubMed Web of Science ®Google Scholar
• Khera, M., & Lipshultz, L.I. (2007). The role of testosterone replacement therapy following radical prostatectomy. The Urologic Clinics of North America, 34, 549–553, vi.
   PubMed Web of Science ®Google Scholar
• Kingsberg, S. (2007). Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. Journal of Sexual Medicine, 4(Suppl. 3), 227–234.
   PubMedGoogle Scholar
• Kingsberg, S., Shifren, J., Wekselman, K., Rodenberg, C., Koochaki, P., & Derogatis, L. (2007). Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in post menopausal women with hypoactive sexual desire disorder. Journal of Sexual Medicine, 4, 1001–1008.
   PubMed Web of Science ®Google Scholar
• Krapf, J.M., & Simon, J.A. (2009). The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas, 63, 213–219.
   PubMed Web of Science ®Google Scholar
• Kupelian, V., Page, S.T., Araujo, A.B., Travison, T.G., Bremner, W.J., & McKinlay, J.B. (2006). Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism, 91, 843–850.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Belanger, A., Labrie, C., Candas, B., Cusan, L., & Gomez, J.L. (2007). Bioavailability and metabolism of oral and percutaneous dihydroepiandrosterone in postmenopausal women. Journal of Steroid Biochemistry & Molecular Biology, 107, 57–69.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Luu-The, V., Belanger, A., Lin, S-X., Simard, J., Pelletier, G., et al. (2005). Is dihydroepiandrosterone a hormone? Journal of Endocrinology, 187, 169–196.
   PubMed Web of Science ®Google Scholar
• Laumann, E.O., Paik, A., & Rosen, R.C. (1998). Sexual dysfunction in the United States: prevalence and predictors. JAMA, 281, 537–544.
   Web of Science ®Google Scholar
• Leiblum, S.R., Koochaki, P.E., Rodenberg, C.A., Barton, I.P., & Rosen, R.C. (2006). Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause, 13, 46–56.
   PubMed Web of Science ®Google Scholar
• Lindau, S.T., Schumm, L.P., Laumann, E.O., Levinson, W., O'Muircheartaigh, C.A., & Waite, L.J. (2007). A study of sexuality and health among older adults in the United States. New England Journal of Medicine, 357, 762–774.
   PubMed Web of Science ®Google Scholar
• Liu, P.Y., Baker, H.W., Jayadev, V., Zacharin, M., Conway, A.J., & Handelsman, D.J. (2009). Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. Journal of Clinical Endocrinology and Metabolism, 94, 801–808.
   PubMed Web of Science ®Google Scholar
• Lobo, R.A., Rosen, R.C., Yang, H.M., Block, B., & van Der Hoop, R.G. (2003). Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in post menopausal women with hypoactive sexual desire. Fertility and Sterility, 79, 1341–1352.
   PubMed Web of Science ®Google Scholar
• Mazer, N.A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids, 74, 512–519.
   PubMed Web of Science ®Google Scholar
• Mazer, N.A., Leiblum, S.R., & Rosen, R.C. (2000). The Brief Index of Sexual Functioning for Women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause, 7, 350–363.
   PubMed Web of Science ®Google Scholar
• Mercer, C.H., Fenton, K.A., Johnson, A.M., Wellings, K., Macdowall, W., McManus, S., et al. (2003). Sexual function problems and help seeking behaviour in Britain: national probability sample survey. BMJ, 327, 426–427.
   PubMed Web of Science ®Google Scholar
• Mimoun, S., & Wylie, K. (2009). Female sexual dysfunctions: definitions and classification. Maturitas, 63, 116–118.
   PubMed Web of Science ®Google Scholar
• Morales, A., Schulman, C.C., Tostain, J., & Wu, C.W. (2006). Testosterone deficiency syndrome (TDS) needs to be named appropriately the importance of accurate terminology. European Urology, 50, 407–409.
   PubMed Web of Science ®Google Scholar
• Moreira, E.D., Glasser, D.B., Nicolosi, A., Duarte, F.G., & Gingell, C.; GSSAB Investigators' Group. (2008). Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU International, 101, 1005–1011.
   PubMed Web of Science ®Google Scholar
• Nathorst Boos, J., Floter, A., Jarkander Rolff, M., Carlstrom, K., & Schoultz, B. (2006). Treatment with percutaneous testosterone gel in post menopausal women with decreased libido effects on sexuality and psychological well-being. Maturitas, 53, 11–18.
   PubMedGoogle Scholar
• Ness, R.B., Albano, J.D., McTiernan, A., & Cauley, J.A. (2009). Influence of estrogen plus testosterone supplementation on breast cancer. Archives of Internal Medicine, 169, 41–46.
   PubMed Web of Science ®Google Scholar
• Nieschlag, E. (2006). Testosterone treatment comes of age: new options for hypogonadal men. Clinical Endocrinology (Oxford), 65, 275–281.
   PubMed Web of Science ®Google Scholar
• Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005a). Investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 8, 56–58.
   PubMedGoogle Scholar
• Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005b). Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. International Journal of Andrology, 28, 125–127.
   PubMed Web of Science ®Google Scholar
• Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2005c). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. European Urology, 48, 1–4.
   PubMed Web of Science ®Google Scholar
• Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al. (2006). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU Recommendations. Journal of Andrology, 27, 135–137.
   PubMed Web of Science ®Google Scholar
• Nijland, E.A., Weijmar Schultz ,W.C., Nathorst-Boös, J., Helmond, F.A., Van Lunsen, R.H., Palacios, S., et al. (2008). Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. Journal of Sexual Medicine, 5, 646–656.
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. (2005). The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause, 12, 496–511.
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. (2010). Estrogen and progesterone use in post menopausal women: 2010 position statement of the North American Menopause Society. Menopause, 17, 242–255.
   PubMed Web of Science ®Google Scholar
• Paik, A., & Laumann, E.O. (2006). Prevalence of women's sexual problems in the USA. In I. Goldstein, C. Meston, S.R. Davis, & A.M. Traish (Eds), Women's sexual function and dysfunction: study, diagnosis and treatment. London: Taylor & Francis.
   Google Scholar
• Panjari, M., Bell, R.J., Jane, F., Adams, J., Morrow, C., & Davis, S.R. (2009). The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas, 63, 240–245.
   PubMed Web of Science ®Google Scholar
• Panjari, M., & Davis, S.R. (2007). DHEA therapy for women: effect on sexual function and wellbeing. Human Reproduction Update, 13, 239–248.
   PubMed Web of Science ®Google Scholar
• Panjari, M., & Davis, S.R. (2010). DHEA for postmenopausal women: a review of the evidence. Maturitas, 66, 172–179.
   PubMed Web of Science ®Google Scholar
• Parasrampuria, J., Schwarz, K., & Petesch, R. (1998). Quality control of dihydroepiandrosterone dietary supplement products. JAMA, 280, 1565.
   PubMed Web of Science ®Google Scholar
• Parsons, J.K., Carter, H.B., Platz, E.A., Wright, E.J., Landis, P., & Metter, E.J. (2005). Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiology, Biomarkers & Prevention, 14, 2257–2260.
   PubMed Web of Science ®Google Scholar
• Pitkin, J., & Rees, M.; British Menopause Society Council. (2008). Urogenital atrophy. Menopause International, 14, 136–137.
   PubMedGoogle Scholar
• Rhoden, E.L., Estrada, C., Levine, L., & Morgentaler, A. (2003). The value of pituitary magnetic resonance imaging in men with hypogonadism. Journal of Urology, 170, 795–798.
   PubMed Web of Science ®Google Scholar
• Roddam, A.W., Allen, N.E., Appleby, P., & Key, T.J. (2008). Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute, 100, 170–183.
   PubMed Web of Science ®Google Scholar
• Rosen, R., Brown, C., Leiblum, S., Heiman, J., Meston, C., Shabsigh, R., et al. (2000). Female sexual function index. Journal of Sex & Marital Therapy, 26, 191–208.
   PubMed Web of Science ®Google Scholar
• Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M., & Raff, H. (2007). Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405–413.
   PubMed Web of Science ®Google Scholar
• Santen, R.J., Allred, D.C., Ardoin, S.P., Archer, D.F., Boyd, N., Braunstein, G.D., et al. (2010). Postmenopausal hormone therapy: an Endocrine Society Scientific Statement. Journal of Clinical Endocrinology and Metabolism, 95(Suppl. 1), S1–S66.
   Web of Science ®Google Scholar
• Santoro, N., Torrens, J., Crawford, S., Allsworth, J.E., Finkelstein, J.S., Gold, E.B., et al. (2005). Correlates of circulating androgens in mid-life women: the Study of Women's Health across the Nation (SWAN). Journal of Clinical Endocrinology and Metabolism, 90, 4836–4845.
   PubMed Web of Science ®Google Scholar
• Sarosdy, M.F. (2007). Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 109, 536–541.
   Google Scholar
• Sarrel, P., Dobay, B., & Wilta, B. (1998). Estrogen and estrogen androgen replacement in postmenopausal women dissatisfied with estrogen only therapy. Sexual behaviour and neuroendocrine responses. Journal of Reproductive Medicine, 43, 847–856.
   PubMed Web of Science ®Google Scholar
• Schousboe, J.T., Taylor, B.C., Fink, H.A., Kane, R.L., Cummings, S.R., Orwoll, E.S., et al. (2007). Cost effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA, 298, 629–637.
   PubMed Web of Science ®Google Scholar
• Schover, L.R. (2008). Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk? Fertility and Sterility, 90, 129–140.
   PubMed Web of Science ®Google Scholar
• Shabsigh, A., Kang, Y., Shabsign, R., Gonzalez, M., Liberson, G., Fisch, H., et al. (2005). Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. Journal of Sexual Medicine, 2, 716–721.
   PubMed Web of Science ®Google Scholar
• Shabsigh, R., Crawford, E.D., Nehra, A., & Slawin, K.M. (2008). Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. International Journal of Impotence Research, 21, 9–23.
   PubMed Web of Science ®Google Scholar
• Shabsigh, R., Kaufman, J.M., Steidle, C., & Padma-Nathan, H. (2004). Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. Journal of Urology, 172, 658–663.
   PubMed Web of Science ®Google Scholar
• Sherwin, B.B., Gelfand, M.M., & Brender, W. (1985). Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in the surgical menopause. Psychosomatic Medicine, 47, 339–351.
   PubMed Web of Science ®Google Scholar
• Shifren, J.L., & Avis, N.E. (2007). Surgical menopause: effects on psychological well-being and sexuality. Menopause, 14, 586–591.
   PubMed Web of Science ®Google Scholar
• Shifren, J.L., Braunstein, G.D., Simon, J.A., Casson, P.R., Buster, J.E., Redmond, G.P., et al. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 343, 682–688.
   PubMed Web of Science ®Google Scholar
• Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics and Gynecology, 112, 970–978.
   PubMed Web of Science ®Google Scholar
• Shufelt, C.L., & Braunstein, G.D. (2008). Testosterone and the breast. Menopause International, 14, 117–122.
   PubMedGoogle Scholar
• Shufelt, C.L., & Braunstein, G.D. (2009). Safety of testosterone use in women. Maturitas, 63, 63–66.
   PubMed Web of Science ®Google Scholar
• Silvain, M. (2009). Sexual response models in women. Maturitas, 63, 112–115.
   PubMed Web of Science ®Google Scholar
• Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., et al. (2005). Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. Journal of Clinical Endocrinology and Metabolism, 90, 5226–5233.
   PubMed Web of Science ®Google Scholar
• Somboonporn, W., Bell, R.J., & Davis, S.R. (2005). Testosterone for peri and postmenopausal women. Cochrane Database of Systematic Reviews, 4, Art. No.: CD004509; doi: 10.1002/14651858.CD004509.pub2.
   Google Scholar
• Spencer, J.B., Klein, M., Kumar, A., & Azziz, R. (2007). The age-associated decline of androgens in reproductive age and menopausal Black and White women. Journal of Clinical Endocrinology and Metabolism, 92, 4730–4733.
   PubMed Web of Science ®Google Scholar
• Swerdloff, R.S., & Wang, C. (2008). Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clinical Chemistry, 54, 458–460.
   PubMed Web of Science ®Google Scholar
• Tamimi, R.M., Hankinson, S.E., Chen, W.Y., Rosner, B., & Colditz, G.A. (2006). Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Archives of Internal Medicine, 166, 1483–1489.
   PubMed Web of Science ®Google Scholar
• Teplin, V., Vittinghoff, E., Lin, F., Learman, L.A., & Richter, H.E., & Kuppermann, M. (2007). Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstetrics and Gynecology, 109, 347–354.
   PubMed Web of Science ®Google Scholar
• Thom, M.H., Collins, W.P., & Studd, J.W. (1981). Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. British Journal of Obstetrics and Gynaecology, 88, 426–433.
   PubMedGoogle Scholar
• Thompson, I.M., Ankerst, D.P., Chi, C., Goodman, P.J., Tangen, C.M., Lucia, M.S., et al. (2006a). Assessing prostate cancer risk: results from the prostate cancer prevention trial. Journal of the National Cancer Institute, 98, 529–534.
   PubMed Web of Science ®Google Scholar
• Thompson, I.M., Carroll, P.R., & Carducci, M.A. (2006b). Recommendations for defining and treating high risk localized prostate cancer. Journal of Urology, 176, S6–S10.
   PubMed Web of Science ®Google Scholar
• van der Stege, J.G., Groen, H., van Zadelhoff, S.J., Lambalk, C.B., Braat, D.D., van Kasteren, Y.M., et al. (2008). Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause, 15, 23–31.
   PubMed Web of Science ®Google Scholar
• Van Staa, T.P., & Sprafka, J.M. (2009). Study of adverse outcomes in women using testosterone therapy. Maturitas, 62, 76–80.
   PubMed Web of Science ®Google Scholar
• Vermeulen, A. (2005). Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. Journal of Endocrinological Investigation, 28, 28–31.
   PubMedGoogle Scholar
• Veronelli, A., Mauri, C., Zecchini, B., Peca, M.G., Turri, O., Valitutti, M.T., et al. (2009). Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report. Journal of Sexual Medicine, 6, 1561–1568.
   PubMed Web of Science ®Google Scholar
• Walters, K.A., Allan, C.M., & Handelsman, D.J. (2008). Androgen actions and the ovary. Biology of Reproduction, 78, 380–389.
   PubMed Web of Science ®Google Scholar
• Wang, C., Catlin, D.H., Demers, L.M., Starcevic, B., & Swerdloff, R.S. (2004). Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 89, 534–543.
   PubMed Web of Science ®Google Scholar
• Wang, C., Nieschlag, E., Swerdloff, R.S., Behre, H., Hellstrom, W.J., Gooren, L.J., et al. (2009). ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 12, 5–12.
   PubMed Web of Science ®Google Scholar
• Wang, C., Plymate, S., Nieschlag, E., & Paulsen, C.A. (1981). Salivary testosterone in men: further evidence of a direct correlation with free serum testosterone. Journal of Clinical Endocrinology and Metabolism, 53, 1021–1024.
   PubMed Web of Science ®Google Scholar
• Warnock, J.K., Swanson, S.G., Borel, R.W., Zipfel, L.M., & Brennan, J.J. (2005). Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause, 12, 374–384.
   PubMed Web of Science ®Google Scholar
• Weil, S., Vendola, K., Zhou, J., & Bondy, C.A. (1999). Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. Journal of Clinical Endocrinology and Metabolism, 84, 2951–2956.
   PubMed Web of Science ®Google Scholar
• Wierman, M.E., Basson, R., Davis, S.R., Khosla, S., Miller, K.K., Rosner, W., et al. (2006). Androgen therapy in women: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 3697–3710.
   PubMed Web of Science ®Google Scholar
• Wierman, M.E., Nappi, R.E., Avis, N., Davis, S.R., Labrie, F., Rosner, W., et al. (2010). Endocrine aspects of women's sexual function. Journal of Sexual Medicine, 7, 561–585.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1999). WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. Cambridge: Cambridge University Press.
   Google Scholar
• Wu, F.C., Tajar, A., Beynon, J.M., Pye, S.R., Silman, A.J., Finn, J.D., et al. (2010). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine, 363, 123–135.
   PubMed Web of Science ®Google Scholar
• Wylie, K.R., & Davies-South, D. (2004). A study of treatment choices in men with erectile dysfunction and reduced androgen levels. Journal of Sex & Marital Therapy, 30, 107–114.
   PubMed Web of Science ®Google Scholar
• Wylie, K.R., & Hallam-Jones, R. (2009). Inhibited arousal in women. Journal of Family Psychotherapy, 20, 150–176.
   Google Scholar
• Wylie, K.R., & Malik, F. (2009). A review of drug treatment for female sexual dysfunction. International Journal of STD & AIDS, 20, 671–674.
   PubMed Web of Science ®Google Scholar
• Zitzmann, M., & Nieschlag, E. (2007). Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 92, 3844–3853.
   PubMed Web of Science ®Google Scholar